These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 35300128)

  • 1.
    Zhang XZ; Chen MJ; Fan PM; Jiang W; Liang SX
    Int J Gen Med; 2022; 15():2727-2745. PubMed ID: 35300128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
    Jiang Y; Yu L; Hu Q; Kang Y; You J; Huang C; Xu X; Chen L
    Mol Immunol; 2023 Jan; 153():226-237. PubMed ID: 36563642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma.
    Song S; Deng X; Jiang S; Tian C; Han J; Chai J; Li N; Yan Y; Luo Z
    J Clin Lab Anal; 2022 Nov; 36(11):e24662. PubMed ID: 36181310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.
    Fan K; Zhang BH; Han D; Sun YC
    BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZC3H12D is a prognostic biomarker associated with immune cell infiltration in lung adenocarcinoma.
    Gong W; Dai W; Wei H; Chen Y; Zheng Z
    Transl Cancer Res; 2020 Oct; 9(10):6128-6142. PubMed ID: 35117224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.
    Wei Q; Miao T; Zhang P; Jiang B; Yan H
    Front Genet; 2022; 13():984575. PubMed ID: 36159963
    [No Abstract]   [Full Text] [Related]  

  • 7. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.
    Zhang X; Wu Z; Ma K
    BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-testis antigen KK-LC-1 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma.
    Kang Y; Gan Y; Jiang Y; You J; Huang C; Chen Q; Xu X; Chen F; Chen L
    BMC Cancer; 2022 Jul; 22(1):834. PubMed ID: 35907786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The EMT-Related Genes GALNT3 and OAS1 are Associated with Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma.
    Luo D; Fang M; Shao L; Wang J; Liang Y; Chen M; Gui X; Yan J; Wang W; Yu L; Fan X; Wu Q
    Front Biosci (Landmark Ed); 2023 Oct; 28(10):271. PubMed ID: 37919050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma.
    Yang B; Ji LL; Xu HL; Li XP; Zhou HG; Xiao T; Li XH; Gao ZY; Li JZ; Zhang WD; Wang GS; Li MJ
    J Inflamm Res; 2021; 14():2389-2401. PubMed ID: 34163207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMICA1 is a diagnostic and prognostic biomarker and induces immune cells infiltration by activating cGAS-STING signaling in lung adenocarcinoma.
    Feng Z; Zhang Y; He M; Han Y; Cai C; Liu S; Liu P; Chen Y; Shen H; Zeng S
    Cancer Cell Int; 2022 Mar; 22(1):111. PubMed ID: 35248033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma.
    Bian T; Zheng M; Jiang D; Liu J; Sun H; Li X; Liu L; Zhang J; Liu Y
    Cancer Cell Int; 2021 Mar; 21(1):144. PubMed ID: 33653340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma.
    Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH
    World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
    Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
    Front Immunol; 2021; 12():724741. PubMed ID: 34335635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPOCK2 Serves as a Potential Prognostic Marker and Correlates With Immune Infiltration in Lung Adenocarcinoma.
    Zhao J; Cheng M; Gai J; Zhang R; Du T; Li Q
    Front Genet; 2020; 11():588499. PubMed ID: 33244319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent prognostic implications of
    Ma C; Luo H; Cao J; Gao C; Fa X; Wang G
    J Cancer; 2020; 11(23):7009-7022. PubMed ID: 33123291
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of
    Bian T; Zhang W; Wang F; Chu X; Pan X; Ruan J; Yu S; Liu L; Sun H; Qiu H; Li Y; Tang J; Zhao X; Zhang H
    Comb Chem High Throughput Screen; 2023; 26(14):2452-2468. PubMed ID: 37038295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker.
    Shen X; Mo X; Tan W; Mo X; Li L; Yu F; He J; Deng Z; Xing S; Chen Z; Yang J
    Pathol Oncol Res; 2022; 28():1610754. PubMed ID: 36419650
    [No Abstract]   [Full Text] [Related]  

  • 19. MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma.
    Li M; Ren H; Zhang Y; Liu N; Fan M; Wang K; Yang T; Chen M; Shi P
    Front Oncol; 2022; 12():772686. PubMed ID: 35174083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma.
    Zhang YH; Zeng J; Liu XS; Gao Y; Kui XY; Liu XY; Zhang Y; Pei ZJ
    Front Endocrinol (Lausanne); 2022; 13():1013238. PubMed ID: 36299451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.